Genetic and Molecular Mechanisms of Ovarian Insufficiency

Premature ovarian insufficiency (POI) arises from early depletion or dysfunction of the ovarian follicle reserve, leading to amenorrhoea, hypoestrogenism and elevated gonadotrophins before 40 years of age. Its aetiology is highly heterogeneous, encompassing monogenic and polygenic contributions that converge on core processes of ovarian development and maintenance. Central molecular mechanisms include defects in DNA damage repair and homologous recombination, perturbations of meiosis and chromosome cohesion, dysregulated signalling pathways governing folliculogenesis and oocyte survival, and imbalances in cellular metabolism and redox homeostasis. Advances in high-throughput sequencing have revealed both loss- and gain-of-function variants in genes encoding transcription factors, DNA repair proteins, structural cohesion components and non-coding RNA regulators. In parallel, emerging evidence implicates cell-death modalities such as ferroptosis and apoptosis in follicle attrition. Illuminating these pathways has transformed diagnostic genetic screening and opened prospects for targeted interventions aimed at preserving ovarian reserve or restoring follicular function, with broad implications for female fertility and long-term health.

Research from Nature Portfolio

Recent studies employing whole-exome sequencing in large POI cohorts have uncovered nearly two hundred pathogenic or likely pathogenic variants across known and novel genes, expanding the catalogue of molecular players in gonadogenesis, meiosis and folliculogenesis. These efforts refined genotype–phenotype correlations, demonstrating a greater genetic burden in primary amenorrhoea and informing more comprehensive diagnostic panels. Complementary mechanistic work has shown that loss of a key nuclear transcription regulator disrupts lipid metabolism and redox balance in oocytes, triggering ferroptotic cell death via aberrant NF2–YAP signalling. Pharmacological blockade of ferroptosis in experimental models was sufficient to rescue follicular survival, highlighting a promising therapeutic strategy for preserving ovarian function.

Genetic and Molecular Mechanisms of Ovarian Insufficiency publication trend

The graph below shows the total number of articles in genetic and molecular mechanisms of ovarian insufficiency across all publications each year (not limited to Nature Index journals).

Technical terms

Premature ovarian insufficiency (POI): Early loss or dysfunction of ovarian follicles before age 40, characterised by amenorrhoea, low oestrogen and high gonadotrophins.

Folliculogenesis: The process by which primordial follicles develop through stages to become pre-ovulatory follicles.

Granulosa cells: Somatic cells surrounding oocytes that support follicle growth, hormone production and oocyte maturation.

Ferroptosis: Iron-dependent form of regulated cell death driven by lipid peroxidation and reactive oxygen species.

Whole-exome sequencing (WES): High-throughput sequencing technique targeting the protein-coding regions of the genome to identify genetic variants.

Loss-of-function variant: A genetic alteration that reduces or abolishes the activity of the encoded protein, often contributing to disease.

References

1. Landscape of pathogenic mutations in premature ovarian insufficiency. Nature Medicine (2023).
2. LRRC4 Deficiency Drives Premature Ovarian Insufficiency by Disrupting Metabolic Homeostasis in Granulosa Cells. Advanced Science (2025).
3. TP63 gain-of-function mutations cause premature ovarian insufficiency by inducing oocyte apoptosis. Journal of Clinical Investigation (2023).
4. Premature Ovarian Insufficiency: Past, Present, and Future. Frontiers in Cell and Developmental Biology (2021).
5. BNC1 deficiency-triggered ferroptosis through the NF2-YAP pathway induces primary ovarian insufficiency. Nature Communications (2022).